ARTICLE | Clinical News
Fluvoxamine CR: Began Phase III testing
August 16, 1999 7:00 AM UTC
Solvay Pharmaceuticals Inc., Marietta, Ga. Product: Fluvoxamine CR Business: Neurological Therapeutic category: Neurotransmission Target: Serotonin Description: Controlled-release formulation of Luvo...